Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Insilico Medicine Receives IND Approval from FDA for ISM8969, an AI-empowered Potential Best-in-class NLRP3 Inhibitor
      Biotech

      Insilico Medicine Receives IND Approval from FDA for ISM8969, an AI-empowered Potential Best-in-class NLRP3 Inhibitor

      January 24, 2026
      Next-Generation Sequencing Market worth $29.53 billion by 2030 | MarketsandMarkets™
      Biotech

      Next-Generation Sequencing Market worth $29.53 billion by 2030 | MarketsandMarkets™

      January 23, 2026
      Resolve M Therapeutics exits from stealth
      Biotech

      Resolve M Therapeutics exits from stealth

      January 22, 2026
      CannaLean Biotechs Announces Positive Completion of First-in-Human Feasibility Study of Its Novel CBD-Based Lipid-Lowering Therapy
      Biotech

      CannaLean Biotechs Announces Positive Completion of First-in-Human Feasibility Study of Its Novel CBD-Based Lipid-Lowering Therapy

      January 21, 2026
      EQT Life Sciences co-leads EUR 51 million Series B in Exciva to advance its Alzheimer’s therapy into clinical Phase 2
      Biotech

      EQT Life Sciences co-leads EUR 51 million Series B in Exciva to advance its Alzheimer’s therapy into clinical Phase 2

      January 20, 2026
      WuXi AppTec Receives Double “A” Rating from CDP for Climate Change and Water Security Leadership
      Biotech

      WuXi AppTec Receives Double “A” Rating from CDP for Climate Change and Water Security Leadership

      January 19, 2026
      Crosswalk Therapeutics Secures National MPS Society Grant to Address Unmet Skeletal Disease in Morquio A Syndrome
      Biotech

      Crosswalk Therapeutics Secures National MPS Society Grant to Address Unmet Skeletal Disease in Morquio A Syndrome

      January 18, 2026
      Doseology Files Annual Information Form (AIF), Strengthening Public Disclosure Record AIF Filing Enhances Transparency and Provides Consolidated Disclosure for Investors
      Biotech

      Doseology Files Annual Information Form (AIF), Strengthening Public Disclosure Record AIF Filing Enhances Transparency and Provides Consolidated Disclosure for Investors

      January 17, 2026
      /C O R R E C T I O N — Net Health Systems, Inc./
      Biotech

      /C O R R E C T I O N — Net Health Systems, Inc./

      January 16, 2026
      JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth
      Biotech

      JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth

      January 15, 2026
      « 1 2 3 4 5 6 … 133 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026